Topotecan in Treating Patients With Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Randomized phase II trial to study the effectiveness of topotecan in treating
patients who have myelodysplastic syndrome.